| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 1430 | FETNIM Precursor |
1430.0010: 10 mg per vial 1430.0020: 20 mg per vial Please inquire for customized filling and bulk quantities. 
|
|
Precursor for [18F]FETNIM
|
||
| Molar Mass: 411.43 | ||
| C17H21N3O7S | ||
| [163714-99-6] | ||
| Colourless to yellowish oil packaged in dark glass crimp cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H NMR spectrum |
||
|
Chemical Name: CA index name: 1,3-Dioxolane-4-methanol, 2,2-dimethyl-5-[(2-nitro-1H-imidazol-1-yl)methyl]-, 4-methylbenzenesulfonate (ester), (4R-trans)- |
||
|
Synonymes: FETNIM precursor |
||
|
Literature: 1. Yang D.J. et al. Development of F-18-labeled Fluoroerythro-nitroimidazole as a PET agent for imaging Tumor Hypoxia. Radiology 1995, 194, 795-800. |
||
| 2. Grönroos T. et al. Pharmacokinetics of [18F]FETNIM, A Potential Hypoxia Marker for PET. J. Nucl. Med. 2001, 42, 1397-1404. | ||
| 3. Lethiö K. et al. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59, 971-982. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1